STAR Pharmaceutical Limited announced earnings results for the third quarter ended September 30, 2019. For the third quarter, the company announced sales was CNY 65.250 million compared to CNY 51.458 million a year ago. Operating loss was CNY 4.773 million compared to CNY 482,000 a year ago. Net loss was CNY 2.959 million compared to CNY 267,000 a year ago. Basic loss per share was CNY 0.0645 compared to CNY 0.0058 a year ago. For the nine months, sales was CNY 277.698 million compared to CNY 156.064 million a year ago. Operating loss was CNY 12.425 million compared to operating Income of CNY 7.874 million a year ago. Net loss was CNY 11.969 million compared to net income of CNY 9.728 million a year ago. Basic loss per share was CNY 0.2603 compared to basic earnings per share of CNY 0.2094 a year ago.